These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6768906)

  • 1. Mass screening: is it cost-effective?
    Clayman CB
    JAMA; 1980 May 23-30; 243(20):2067-8. PubMed ID: 6768906
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention and screening. Part II: Critical appraisal of articles on screening.
    Soares I; Carneiro AV
    Rev Port Cardiol; 2003 Jan; 22(1):117-30. PubMed ID: 12712815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision making in clinical preventive medicine.
    Silverstein MD
    Prim Care; 1989 Mar; 16(1):9-30. PubMed ID: 2495542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The battle over full-body scans.
    Carson P
    Manag Care; 2001 Sep; 10(9):43-6. PubMed ID: 11570354
    [No Abstract]   [Full Text] [Related]  

  • 5. [35 years of prevention of the Thalassemia].
    Amato A; Lerone M; Grisanti P; Cappabianca MP; Ponzini D; Gianni D; Di Biagio P; Rinaldi S; D'Arcangeli N; Sidorini B; Piscitelli R
    Ig Sanita Pubbl; 2011; 67(1):61-81. PubMed ID: 21468155
    [No Abstract]   [Full Text] [Related]  

  • 6. Is preventive medical care worth the cost?
    Szucs TD; Belisari A; Mantovani LG
    Biologicals; 1997 Jun; 25(2):247-52. PubMed ID: 9236062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and cost containment.
    Susser M
    Bull N Y Acad Med; 1980; 56(1):45-52. PubMed ID: 6766765
    [No Abstract]   [Full Text] [Related]  

  • 8. [10 years of assessing prevention and early diagnosis programmes by the Federal Joint Committee of Germany - a methodological analysis].
    Bertelsmann H; Perleth M; Matthias K
    Gesundheitswesen; 2013 Jan; 75(1):7-12. PubMed ID: 22836934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis prevention through screening: will it be cost effective?
    Torgerson DJ; Reid DM
    Baillieres Clin Rheumatol; 1993 Oct; 7(3):603-22. PubMed ID: 8293493
    [No Abstract]   [Full Text] [Related]  

  • 10. Expanded HIV screening in the US is cost-effective.
    Andrawiss M
    Drug Discov Today; 2005 Apr; 10(7):452-3. PubMed ID: 15809186
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiological issues in health promotion and cost containment.
    Philips BV
    Health Values; 1988; 12(5):32-8. PubMed ID: 10312674
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in disease prevention: assessing the benefits of prevention.
    McGinnis JM
    Bull N Y Acad Med; 1980; 56(1):38-44. PubMed ID: 6766764
    [No Abstract]   [Full Text] [Related]  

  • 13. Public health in crisis: the economic consequences of inaction on preventive medicine.
    Fahs MC
    Mt Sinai J Med; 1992 Nov; 59(6):469-78. PubMed ID: 1480200
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Prevention doesn't pay?' Logic explodes this myth.
    Victoroff MS
    Manag Care; 2001 Sep; 10(9):56-7. PubMed ID: 11570357
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost effectiveness of universal diabetes screening.
    Manag Care Interface; 2004 Oct; 17(10):59-60. PubMed ID: 15535080
    [No Abstract]   [Full Text] [Related]  

  • 16. U.S. Preventive Services Task Force recommendations highly authoritative.
    James BC
    Manag Care; 2011 Dec; 20(12):5. PubMed ID: 22259870
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of colorectal cancer screening.
    Budenholzer B; Welch HG
    JAMA; 2001 Jan 24-31; 285(4):407; author reply 408. PubMed ID: 11242411
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of colorectal cancer screening.
    Donohoe M
    JAMA; 2001 Jan 24-31; 285(4):407; author reply 408. PubMed ID: 11242412
    [No Abstract]   [Full Text] [Related]  

  • 19. Liabilities of cutting costs through preventive medicine and regionalization.
    Shenkin HA
    Health Aff (Millwood); 1996; 15(3):285. PubMed ID: 8854536
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cost benefit analysis and preventive screening].
    Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1981 Feb; 125(7):276-8. PubMed ID: 6785657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.